1. Current and Emerging Applications of Droplet Digital PCR in Oncology: An Updated Review
   Susana Olmedillas-López et al, 2022, Molecular Diagnosis & Therapy CrossRef
2. Electrochemiluminescent CdS Quantum Dots Biosensor for Cancer Mutation Detection at Different Positions on Linear DNA Analytes
   Fan Yang et al, 2023, Analytical Chemistry CrossRef
3. Diagnostic Accuracy of Droplet Digital PCR and Amplification Refractory Mutation System PCR for Detecting EGFR Mutation in Cell-Free DNA of Lung Cancer: A Meta-Analysis
   Caichen Li et al, 2020, Frontiers in Oncology CrossRef
4. The role of circulating free DNA in the management of NSCLC
   Riziero Esposito Abate et al, 2019, Expert Review of Anticancer Therapy CrossRef
5. The Validity and Predictive Value of Blood-Based Biomarkers in Prediction of Response in the Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review
   Frederik van Delft et al, 2020, Cancers CrossRef
6. The expression level of CSDAP1 in lung cancer and its clinical significance
   Tongbai Xu et al, 2018, Oncology Letters CrossRef
7. Concordance of changes in the extracellular DNA of blood plasma and DNA of tumor tissue using the example of EGFR gene mutations in patients with non-small cell lung cancer
   A. A. Gneusheva et al, 2018, Laboratornaya sluzhba CrossRef
8. Differences in the genomic profiles of cell‐free DNA between plasma, sputum, urine, and tumor tissue in advanced NSCLC
   Zhen Wu et al, 2019, Cancer Medicine CrossRef
9. Comparison of the SuperARMS and Droplet Digital PCR for Detecting EGFR Mutation in ctDNA From NSCLC Patients
   Wei-neng Feng et al, 2018, Translational Oncology CrossRef
10. Comparative assessment of NOIR-SS and ddPCR for ctDNA detection of EGFR L858R mutations in advanced L858R-positive lung adenocarcinomas
    Daisuke Akahori et al, 2021, Scientific Reports CrossRef
11. Elevated NOX4 promotes tumorigenesis and acquired EGFR-TKIs resistance via enhancing IL-8/PD-L1 signaling in NSCLC
    Wen-Jing Liu et al, 2023, Drug Resistance Updates CrossRef
12. Outcomes with liquid biopsy to determine the EGFR mutation status in poor performance status, biopsy-ineligible, advanced NSCLC patients
    Avinash Pandey et al, 2019, Cancer Research, Statistics, and Treatment CrossRef
13. Expression and copy number gains of the RET gene in 631 early and mid stage non‐small cell lung cancer cases
    Ling Tan et al, 2018, Thoracic Cancer CrossRef
14. Molecular Diagnostics for Lung Cancer
    Ashok Kumar et al, 2019, Molecular Diagnostics in Cancer Patients CrossRef
15. An electrochemiluminescence resonance energy transfer biosensor for the detection of circulating tumor DNA from blood plasma
    Xidong Yang et al, 2021, iScience CrossRef
16. Detection of EGFR mutations in non-small cell lung cancer by droplet digital PCR
    Drew F. K. Williamson et al, 2022, PLOS ONE CrossRef
17. Atypical Droplet Digital Polymerase Chain Reaction Patterns That Indicate Uncommon but Clinically Actionable EGFR Mutations in Lung Cancer
    Adam Lechner et al, 2024, Archives of Pathology & Laboratory Medicine CrossRef